Compounds of the formula (I), in which R
1a
—R
1c
, R
2a
, R
2b
, R
3
and R
5
have the meanings indicated in claim
1
, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.
化合物的公式(I),其中R1a-R1c,R2a,R2b,R3和R5具有权利要求1中所示的含义,是
酪氨酸激酶,特别是TIE-2和Raf激酶的
抑制剂,可用于治疗肿瘤等疾病。